Trials / Unknown
UnknownNCT05928520
Pain Management in Pediatric Adenotonsillectomy
Comparison of Analgesic Efficacy of Topical Tramadol Versus Topical Lidocaine in the Control of Post Operative Pain in Children After Tonsillectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 4 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
Tonsillectomy is considered one of the most frequent minor surgeries conducted on a day-case basis on children, and usually associated with pain and sore throat. This study aimed to include 80 children, ASA physical status I\&II aged 4-15 years, and undergoing tonsillectomy. The purpose of this study is to determine the analgesic efficacy of topically applied lidocaine and tramadol in relieving post-operative pain in children following tonsillectomy.
Detailed description
Pain and sore throat following tonsillectomy are typical. As a result, the issue of adequate post-tonsillectomy pain management remains a significant therapeutic obstacle. Several medications, including nonsteroidal anti-inflammatory drugs, corticosteroids and narcotics have been utilised to alleviate pain following tonsillectomy. Nevertheless, they have numerous undesirable negative consequences. NSAIDs may impede hemostasis and increase the propensity for bleeding. Opioid may result in respiratory depression, nausea, and vomiting. Consequently, the major purpose of this study is pain alleviation with minimal adverse effects. This prospective, randomized, double-blind controlled clinical study will include 80 children, undergoing tonsillectomy, to receive either topical tramadol 5% or lidocaine 2%. Modified Visual Analogue Scale (m-VAS), bleeding, nausea, vomiting, sore throat, otalgia, fever, halitosis, and constipation will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol 5% | Topical tramadol 5% |
| DRUG | Lidocaine 2% | Topical Lidocaine 2% |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-09-01
- Completion
- 2024-10-01
- First posted
- 2023-07-03
- Last updated
- 2023-07-11
Source: ClinicalTrials.gov record NCT05928520. Inclusion in this directory is not an endorsement.